Oxandrolone

Anavar · Oxandrin

Anabolic Steroid aas Oral FDA/EMA Label

Half-life

9 hr

Time to Peak

1 hr

Steady State

~2 days

Dose Range

10–80 mg

Frequency

2x daily

Overview

Oral AAS with one of the most extensive published human PK datasets due to ongoing medical use. FDA-approved for weight regain after surgery/trauma, chronic infection, severe burns, Turner syndrome, and HIV wasting. Widely used non-medically due to mild side effect profile. 17-alpha-alkylated but considered less hepatotoxic than most oral AAS. Significant renal excretion (28% unchanged in urine). Harm reduction: While "mild" by AAS standards, still suppresses endogenous testosterone and negatively impacts lipid profiles (reduces HDL significantly). Monitor liver enzymes and lipid panel. 17-alpha-alkylated — do not combine with other hepatotoxic compounds or excessive alcohol.

Mechanism of Action

DHT derivative. 17-alpha-alkylated for oral bioavailability. Does not aromatize. Moderate anabolic, low androgenic. 28% excreted unchanged by kidneys.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Oral 10–80 mg 9 hr 1 hr 2x daily

Storage & Handling

Room temperature — Oral tablets. Store at 20-25C. Protect from light.

Used in Regimens

2 regimens

Data Sources

  • FDA Label Oxandrin (oxandrolone) FDA Prescribing Information
  • Peer-reviewed Karim A et al. Oxandrolone disposition and metabolism in man

Related Tools

Track Oxandrolone with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.